Skip to main content
. 2017 Sep 22;24:195–204. doi: 10.1016/j.ebiom.2017.09.028

Fig. 1.

Fig. 1

CONSORT diagram showing the availability of immunological samples for the vaccine effect prediction analysis of the phase 2 Vacc-4x clinical study.